{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-249235","form_type":"8-K","ticker":"WHWK","cik":"0001422142","company_name":"Whitehawk Therapeutics, Inc.","filed_at":"2022-09-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:55.692651+00:00","generated_at":"2026-06-23T07:58:20.952772+00:00","sec_items":["1.01","3.02","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Aadi Bioscience raises $72.5M in PIPE financing to extend cash runway into 2025","bullets":["PIPE includes 3,373,526 shares at $12.50 and 2,426,493 pre-funded warrants at $12.4999 with $0.0001 exercise price.","Gross proceeds ~$72.5M; expected close Sept. 26, 2022, subject to customary conditions.","Management participated for ~$750,000; led by a life sciences fund with existing investors.","Proceeds to fund PRECISION 1 trial, FYARRO commercial efforts, and general working capital.","Cash runway expected into 2025; preliminary PRECISION 1 data anticipated in H1 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-249235","json":"https://secwatch.observer/filing/0001193125-22-249235.json","markdown":"https://secwatch.observer/filing/0001193125-22-249235.md","text":"https://secwatch.observer/filing/0001193125-22-249235.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1422142/000119312522249235/0001193125-22-249235-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1422142/000119312522249235/d367672d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T07:58:20.952772+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}